2023
DOI: 10.1016/j.ejor.2023.03.032
|View full text |Cite
|
Sign up to set email alerts
|

Fair-split distribution of multi-dose vaccines with prioritized age groups and dynamic demand: The case study of COVID-19

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 11 publications
(2 citation statements)
references
References 90 publications
0
2
0
Order By: Relevance
“…There is a vast body of work that was developed to compare COVID-19 vaccination strategies. Most of the previous research has been devoted to analyze within-country or within-region vaccine allocation [ 17 19 , 21 , 23 , 24 , 26 , 31 , 33 , 74 84 ], some has explored the optimal use of COVID-19 vaccines globally to reduce between- [ 20 , 22 , 85 , 86 ], or within-country inequities [ 84 , 87 , 88 ]. Covid19Vaxplorer adds to previous work with the hope of providing those countries or regions with limited modeling capabilities with a tool for vaccine allocation comparison.…”
Section: Discussionmentioning
confidence: 99%
“…There is a vast body of work that was developed to compare COVID-19 vaccination strategies. Most of the previous research has been devoted to analyze within-country or within-region vaccine allocation [ 17 19 , 21 , 23 , 24 , 26 , 31 , 33 , 74 84 ], some has explored the optimal use of COVID-19 vaccines globally to reduce between- [ 20 , 22 , 85 , 86 ], or within-country inequities [ 84 , 87 , 88 ]. Covid19Vaxplorer adds to previous work with the hope of providing those countries or regions with limited modeling capabilities with a tool for vaccine allocation comparison.…”
Section: Discussionmentioning
confidence: 99%
“…They were also aware that such an action plan necessitates re-planing medical products’ production system and re-allocating/sharing limited health resources among different centers/regions to combat the pandemic as supply chain viability measures [7] , [8] , [9] , [10] , [11] , [12] . The success of such an action plan highly depends on two main problems: a precise enough estimation of the demand for medical products; and an efficient logistics network to produce, stock, distribute, and share such products [13] , [14] , [15] , [16] .…”
Section: Introductionmentioning
confidence: 99%